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sizing,4 as observed in our in vitro compari-
son.1 Moreover, considering the excessively
and surprisingly high regurgitant volumes
observed in vitro with the Carpentier-
Edwards Magna valve, as well as the mini-
mal tolerability of this valve to stent distor-
tion, according to present work and to other
experiences in the literature,5,6 the upsizing
of the Carpentier-Edwards Magna should be,
to our mind, carefully considered.
Unfortunately, “in vivo” comparisons
between different prostheses are difficult
and misleading; several confounding fac-
tors, such as blood viscosity (patient he-
matocrit), heart rate, left ventricle and mi-
tral valve pattern, cardiac output, septum
hypertrophy, systemic hypertension, re-
duced systemic arterial compliance, and ef-
fects of angiotensin-converting enzyme in-
hibitors in hypertensive patients, data that
are rarely reported in clinical studies, are
frequently present. These factors may con-
found the data obtained by echocardio-
graphic studies. Other important factors
such as aortic root anatomy or variability in
surgical skill and implant technique might
indeed affect clinical comparisons. Finally,
echocardiography parameters (ie, effective
orifice area calculated by using the conti-
nuity equation) have inherent variability
that is mainly related to the techniques used
for its measurement, as well as to flow
dependency. For these reasons, we main-
tain that it is hazardous to conclude that a
prosthesis model is the gold standard by
interpreting only clinical results.
The system that we have used has a
virtually rigid arrangement section down-
stream from the aortic valve, which repre-
sents perhaps the single largest distortion
from reality. Attachment of a small com-
pliant device to the downstream section
could give a significantly different system
performance, mimicking an in vivo setting
such as an aorta setting. However, if we
compare two heart valves in this modified
system, we would expect to appreciate the
same differences between the two different
valves. Therefore, the pulse duplicator de-
vice is not really designed to give an accu-
rate representation of the true anatomy;
rather, it is a system that provides an ex-
traordinary and unquestionable bench test
for comparison of different prostheses.
The most striking finding of our study
was the ability to obtain a unique hydrody-
namic comparison of different models of su-
pra-annular tissue valves fitting a 21-mm di-
ameter artificial aortic annulus, regardless of
the labeled manufacturers’ size. This com-
parison can be helpful in assisting surgeons’
decisions.
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Nitric oxide precursors and
congenital cardiac surgery: A
randomized controlled trial of oral
citrulline. Definition of pulmonary
hypertension in Fontan circulation?
To the Editor:
We read with great interest the article
from Smith and colleagues1 describing
the effect of citrulline supplementation in
reducing postoperative pulmonary hyper-
tension. This is very appealing therapy
because it is reported to be effective and
without any side effects.
Nevertheless, we have a concern with
the definition of pulmonary hypertension.
The authors have used the accepted defini-
tion of pulmonary hypertension as a mean
pulmonary arterial pressure of at least 25
mm Hg2 or exceeding 50% of the mean
systemic artery pressure. Although accept-
able for patients presenting with ventricular
or atrioventricular septal defect, as well as
transposition of the great arteries, this def-
inition is more questionable for bidirec-
tional Glenn and Fontan procedures.
A prerequisite for a successful bidirec-
tional Glenn or Fontan procedure would be
a mean pressure of less than 15 mm Hg. In
addition, a pressure of more than 12 mm
Hg in a Fontan circulation would be con-
sidered a suboptimal result.
Taking 25 mm Hg as a limit to describe
high pulmonary pressure in this group in-
duces a significant bias to our point of
view. Assuming that we use 15 mm Hg as
the limit for the Glenn and Fontan group,
all patients (11/11) presented with pressure
of more than 15 mm Hg in the placebo
group, and 9 of 10 patients presented with
this pressure in the citrulline group. Taking
20 mm Hg as a superior limit, 4 of 11 in the
placebo group presented with pressure over
the limit compared with 4 of 10 in the
citrulline group, respectively.
On this basis, we think that groups with
shunt lesions and biventricular repair ver-
sus single-ventricle physiology should not
be evaluated similarly with regard to pul-
monary hypertension.
Another concern, and this is applicable to
both shunt lesions or single-ventricle circula-
tion, is that nothing is reported with regard to
postoperative care, and several confounding
factors can increase or decrease pulmonary
arterial pressures in this period, such as pH,
PO2, sedation, ventricular function, pulmo-
nary wedge or atrial pressures, and inotropic/
vasodilatory support for 48 hours.3
We think these points are of major im-
portance because citrulline levels might not
have been the sole responsible variable for
reducing pulmonary arterial pressure.
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Carbon dioxide embolism induced by
endoscopic saphenous vein
harvesting during coronary artery
bypass grafting
To the Editor:
We read with great interest the article by
Dr Kypson1 reporting a case of carbon di-
oxide embolism during saphenous vein
harvesting for coronary artery bypass graft-
ing (CABG) in a 43-year-old woman. Sa-
phenous venous conduits were harvested
by the endoscopic method with carbon diox-
ide insufflation. On weaning from cardiopul-
monary bypass (CPB), the endoscope was
reinserted to control hemostasis and a mas-
sive gaseous embolism occurred that did not
respond to pharmacologic resuscitation, lead-
ing to the need for reinstitution of the CPB.
Direct inspection revealed a torn saphe-
nofemoral junction that was resewn. Finally,
air locks in the venous circulation and right
side of the heart disappeared and the hemo-
dynamic parameters returned to normal.
Our group2,3 has previously reported on
2 cases that have occurred in more than
1000 procedures to date. We would like to
raise some issues concerning this observa-
tion.
First, although carbon dioxide embo-
lism is clearly due to direct entry into the
injured vein, the cause of this lesion was
not discussed in the article. Reintroduction
of the scope and gas reinsufflation in the
operating tunnel at the end of the operation
to secure hemostasis when liquid and blood
accumulation may have occurred over sev-
eral hours appear, at best, of little use ow-
ing to poor visualization, and they may be
potentially dangerous as this maneuver was
likely responsible for the tear. Hemostasis
is best secured at the time of harvesting and
may be revised by direct visualization of
each venous end ligation through the skin
incisions. We routinely wrap the tunnel site
with circular bandaging immediately after
vein extraction and for the duration of the
cardiac procedure, after which the bandage
is removed, hemostasis double checked by
evacuation (if necessary) of liquid from the
tunnel, and elastic bandaging for 24 hours
postoperatively. Need for direct revision of
leg hemostasis is rare in our experience of
more than 1000 endoscopic vein harvest-
ings.4
Second, although quickly suspected, the
diagnosis of carbon dioxide embolism was
not made before CPB reinstitution, since at
the time of the gaseous reinsufflation, the
transesophageal echocardiographic (TEE)
monitoring was discontinued. Since it has
been shown to be the most effective method
for detection of gaseous embolisms,5 TEE
should always be available during insuffla-
tion.
Last, the author states that this complica-
tion was “unanticipated.”1 Although massive
gaseous embolism with significant clinical
implications is anecdotal,5 it has now been
well described by our group2 and other au-
thors. Moreover, since the total incidence of
introduction of carbon dioxide in the venous
circulation reaches a 17% rate,5 physicians
should certainly be aware of this risk, search
and take into account eventual predisposing
factors,2 provide TEE monitoring during the
whole procedure, and avoid repeated gas in-
sufflations. Endoscopic venous harvesting is
a safe procedure so long as the necessary
precautions are taken.
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Reply to the Editor:
I thank Drs Mommerot and Perrault for
their contributions to the literature regard-
ing endoscopic vein harvesting and for
their comments regarding my recent case
report. I would also like to point out the
following issues in response to their com-
ments.
The cause of the lesion was not dis-
cussed in the article; however, injury to the
saphenofemoral junction consisted of a
partial tear occurring at the time of initial
vein harvest and not at the conclusion of
the operation, when the scope was reintro-
duced into the leg. Nevertheless, carbon
dioxide entry into the vascular space was
the result of reinsufflation at the conclusion
of the case. Drs Mommerot and Perrault are
correct in stating that hemostasis is best
secured at the time of harvesting and reintro-
duction of the scope should be minimized.
However, if necessary, we do re-examine
the tunnel after protamine administration,
albeit carefully.
Intraoperative transesophageal echocar-
diography (TEE) has become a valuable
tool for patients undergoing cardiac sur-
gery. We use this technique on all such
procedures and do not discontinue its use
until the patient is ready for transport to the
intensive care unit. In this case, TEE mon-
itoring had been discontinued because the
sternotomy incision had been closed. Drs
Mommerot and Perrault are correct that
TEE is the most effective method for de-
tection of gaseous embolisms. Had the
probe been in place during reintroduction
of the scope, it might have sooner revealed
the impending problem.
In conclusion, endoscopic vein harvest-
ing is a safe procedure with a very low
complication rate. Although the incidence
of introduction of carbon dioxide into the
venous circulation reaches 17%, the inci-
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